NXTHERA, INC.
MAPLE GROVE, MN

NxThera’s founder, Michael Hoey, lost his father to prostate cancer in 1995. NxThera’s products are being designed to honor his memory. Michael is personally and passionately dedicated to finding humane and effective treatments for prostate and other endourologic conditions. RF energy is applied to convert sterile water to stored thermal energy in the form of vapor, which is convectively delivered to prostate tissue to treat benign prostatic hyperplasia (BPH), and has the potential to be used to treat prostate cancer and kidney cancer in future applications. NxThera's Convective RF Water Vapor Thermal Therapy technology has been studied in several BPH clinical trials and is designed to be a next generation minimally invasive treatment platform for a variety of endourologic conditions. NxThera’s founder, Michael Hoey, lost his father to prostate cancer in 1995. NxThera’s products are being designed to honor his memory. Michael is personally and passionately dedicated to finding humane and effective treatments for prostate and other endourologic conditions. RF energy is applied to convert sterile water to stored thermal energy in the form of vapor, which is convectively delivered to prostate tissue to treat benign prostatic hyperplasia (BPH), and has the potential to be used to treat prostate cancer and kidney cancer in future applications. NxThera's Convective RF Water Vapor Thermal Therapy technology has been studied in several BPH clinical trials and is designed to be a next generation minimally invasive treatment platform for a variety of endourologic conditions.